BioNexus Gene Lab Corp (BGLC)
0.60
0.00 (0.00%)
USD |
NASDAQ |
May 06, 14:24
BioNexus Gene Lab Gross Profit Margin (Quarterly): 11.73% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.73% |
| September 30, 2023 | 13.88% |
| June 30, 2023 | 13.23% |
| March 31, 2023 | 15.52% |
| December 31, 2022 | 11.95% |
| September 30, 2022 | 11.63% |
| June 30, 2022 | 10.62% |
| March 31, 2022 | 11.76% |
| December 31, 2021 | 14.70% |
| September 30, 2021 | 19.83% |
| Date | Value |
|---|---|
| June 30, 2021 | 15.12% |
| March 31, 2021 | 16.89% |
| December 31, 2020 | 9.28% |
| September 30, 2020 | 16.89% |
| June 30, 2020 | 14.43% |
| March 31, 2020 | 21.35% |
| December 31, 2019 | 64.70% |
| September 30, 2019 | 31.75% |
| June 30, 2019 | 21.37% |
| March 31, 2019 | 32.99% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
9.28%
Minimum
Dec 2020
64.70%
Maximum
Dec 2019
18.24%
Average
14.70%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
| Balchem Corp | 32.79% |
| Friedman Industries Inc | 9.00% |
| Solitario Resources Corp | -- |
| Golden Minerals Co | -327.7% |
| Paramount Gold Nevada Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.12% |
| Return on Assets | -27.56% |
| Return on Invested Capital | -34.12% |
| Profit Margin (Quarterly) | 13.57% |
| Operating Margin (Quarterly) | 11.34% |
| Return on Net Operating Assets | -41.62% |